Navigation Links
Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan
Date:8/24/2010

LONDON, Aug. 24 /PRNewswire/ -- While the penetration of picture archiving and communication systems (PACS) in European hospitals is 80 per cent, the modern radiology information system (RIS) that drives PACS has only reached a penetration level of about 41 per cent. Legacy RIS modules ubiquitously dominate the market and many hospitals are reluctant to install a new RIS due to complications associated with training a large group of staff as well as concerns over data migration and security. However, with the third generation of PACS installations, hospitals have realised the importance of investing in a modern RIS. Moreover, they are also recognising the need to purchase RIS and PACS from the same vendor to reduce operational costs.

(Logo: http://photos.prnewswire.com/prnh/20081117/FSLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

New analysis from Frost & Sullivan (http://www.medicalimaging.frost.com), European RIS/PACS Market, finds that the market was valued at $679.4 million in 2009 and estimates this to reach $1,353.3 million in 2016.

"Expanding regulatory initiatives of DICOM and HL7 will make the homegrown RIS solution obsolete, thereby boosting RIS installations from prominent vendors," notes Frost & Sullivan Programme Manager Eramangalath Sujith. "The new slipstream of advanced PACS installations will require hospitals to have a modern RIS system that will drive these PACS."

Old RIS modules are unidirectional systems incapable of driving PACS modules. Unidirectional systems will also lead to unnecessary duplication of data, thereby adding to the operational cost of hospitals. Modern RIS and PACS installations will ensure a single-point desktop access to radiology information and digitised images. This will support enhanced productivity.

The major challenge faced by the RIS/PACS industry is related to people. Hospital staff have been used to legacy RIS modules that have existed for more than 20 years. For a long time, hospitals were only concerned with allocating budgets for PACS installations and making their IT portfolio complete.

"RIS systems used to cost as much as PACS systems about five to six years ago," explains Sujith. "European hospitals allocated budgets only for PACS purchase and not for RIS."

As most RIS and PACS modules are sold separately, hospitals can save between 10-20 per cent (depending on their preliminary requirements) of the total price on their initial RIS/PACS installation. An even more important criterion promoting system adoption is the prospect of reduced operational cost during the long term.

"Vendors for RIS and PACS modules should justify faster return on investments to clients through the purchase of both modules as a combined package," advises Sujith.

If you are interested in more information on Frost & Sullivan's latest study on the European RIS/PACS Market, please send an e-mail to Katja Feick, Corporate Communications, at katja.feick@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country.

European RIS/PACS Market is part of the Medical Imaging Growth Partnership Services programme, which also includes research in the following markets: European Laboratory Information Systems, European C-Arms Market and, Strategic Outlook into Archive Requirements for Digitised Images in Medical Imaging. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.European RIS/PACS Market (M564)Contact:Katja FeickCorporate Communications – EuropeP: +49 (0) 69 7703343E: katja.feick@frost.comhttp://www.frost.comTwitter: twitter.com/frost_sullivan
'/>"/>

SOURCE Frost & Sullivan
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
2. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
3. Study Shows VAPRISOL(R) is Effective in Increasing Serum Sodium Levels and Well-Tolerated in Patients With Euvolemic or Hypervolemic Hyponatremia
4. Younger Adults Increasingly Treated for Heart Disease-related Conditions
5. Increasing Dairy Milk Production with Electrolyzed Drinking Water
6. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
7. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million
8. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
9. Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis
10. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
11. Growing Supply Chain Complexity Increasing Impact on Medical Device Company Operations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... Revenue Prospects by Product Type (Metered Dose Inhalers, Dry ... Respiratory Inhalers - our new study reveals trends, R&D progress, ... If you are involved in this sector you must read this ... revenues streams to 2027, assessing data, trends, opportunities and business prospects ... Discover how ...
(Date:3/29/2017)... NEW YORK , March 29, 2017 ... infection and promote healing of the wound. The industry ... devices and products for the treatment of wounds caused ... that occur due to diseases such as diabetes, skin ... Europe was the largest ...
(Date:3/29/2017)... , March 29, 2017  BioSpecifics Technologies Corp. ... continues to develop collagenase based-therapies with a first ... marketed as XIAFLEX ®  in the U.S. and ... present a corporate overview at the upcoming 16 ... April 5, 2017 at 8:00 a.m. ET in ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... ... squash, announced it has enlisted New York City-based sports and entertainment marketing firm ... and procure sponsorship opportunities for the Professional Squash Association (PSA), which includes first-time ...
(Date:3/29/2017)... ... March 30, 2017 , ... Grass pollen is the main cause of hay fever ... stuff. The season for grass pollen runs from May to July each year; with the ... victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against ...
(Date:3/29/2017)... ... March 30, 2017 , ... Youth Futures International (YFI) premiered ... feedback from high school and college students who have participated in the program every ... and YFI is now accepting applications for enrollment. Visit http://www.ghana.yfiexperience.org to ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sports Brand EXOUS Bodygear ... which retails normally at $29.97; for the remaining days of March, the price will ... reduced to a special price of just $10 (regular retail price $19.97). , The ...
(Date:3/29/2017)... , ... March 29, 2017 , ... ... Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest ... in two southeastern states. Ingredients in HeartBoost, an over the counter heart healthy ...
Breaking Medicine News(10 mins):